Vanguard Capital Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,050
| Closed | -$240K | – | 128 |
|
|
2024
Q4 | $240K | Sell |
9,050
-1,950
| -18% | -$51.7K | 0.26% | 81 |
|
|
2024
Q3 | $318K | Sell |
11,000
-2,034
| -16% | -$58.9K | 0.33% | 66 |
|
|
2024
Q2 | $365K | Buy |
13,034
+2,817
| +28% | +$78.8K | 0.25% | 85 |
|
|
2024
Q1 | $284K | Buy |
10,217
+412
| +4% | +$11.4K | 0.2% | 97 |
|
|
2023
Q4 | $282K | Sell |
9,805
-1,711
| -15% | -$49.3K | 0.23% | 95 |
|
|
2023
Q3 | $382K | Buy |
11,516
+1,331
| +13% | +$44.2K | 0.35% | 65 |
|
|
2023
Q2 | $374K | Buy |
10,185
+360
| +4% | +$13.2K | 0.34% | 68 |
|
|
2023
Q1 | $401K | Sell |
9,825
-89
| -0.9% | -$3.63K | 0.4% | 60 |
|
|
2022
Q4 | $508K | Buy |
9,914
+108
| +1% | +$5.53K | 0.59% | 48 |
|
|
2022
Q3 | $429K | Sell |
9,806
-13,065
| -57% | -$572K | 0.52% | 53 |
|
|
2022
Q2 | $1.2M | Sell |
22,871
-9,513
| -29% | -$499K | 1.35% | 15 |
|
|
2022
Q1 | $1.68M | Sell |
32,384
-6,922
| -18% | -$358K | 1.2% | 16 |
|
|
2021
Q4 | $2.32M | Sell |
39,306
-25,751
| -40% | -$1.52M | 1.67% | 10 |
|
|
2021
Q3 | $2.8K | Buy |
65,057
+30,540
| +88% | +$1.31K | 1.88% | 10 |
|
|
2021
Q2 | $1.35M | Buy |
34,517
+2,327
| +7% | +$91.1K | 1.03% | 21 |
|
|
2021
Q1 | $1.16M | Buy |
32,190
+19,440
| +152% | +$698K | 0.98% | 26 |
|
|
2020
Q4 | $468K | Buy |
+12,750
| New | +$468K | 0.43% | 62 |
|